Patent · US Expired

Unsaturated hydroximic acid derivatives as per abstract inhibitors

US6500823B1 · kind B1 · utility

3Cited by
2References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 2, 2001
Grant dateDec 31, 2002
Priority date
Expiry dateMar 2, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D295/088
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The object of the invention consists of novel unsaturated hydroximic acid derivatives, the process for their preparation and as active substance such as compounds containing pharmaceutical compositions. The novel compounds possess valuable pharmaceutical effects, so they can be used in the treatment of states connected with energy deficiency of the cell caused by PARP inhibition, in diabetes complications, in oxygen deficient status of the heart and brain, in neurodegenerative diseases, in the treatment of autoimmune and/or viral diseases. In formula (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.